Interferon Gamma Counteracts the Angiogenic Switch and Induces Vascular Permeability in Dextran Sulfate Sodium Colitis in Mice
Interferon Gamma Counteracts the Angiogenic Switch and Induces Vascular Permeability in Dextran Sulfate Sodium Colitis in Mice
复制标题
γ干扰素抵消小鼠右旋糖酐硫酸钠结肠炎的血管生成开关并诱导血管通透性
DOI:
10.1097/mib.0000000000000490
复制
发表时间:
2015-10-01
影响因子:
4.9
通讯作者:
Stuerzl, Michael
中科院分区:
文献类型:
--
作者:
Haep, Lisa;Britzen-Laurent, Nathalie;Stuerzl, Michael
Background:Interferon (IFN)- is a central pathogenesis factor in inflammatory bowel disease (IBD) with pleiotropic effects on many different cell types. However, as yet, the immune modulatory functions of IFN- in IBD have been predominantly investigated. Based on previous studies showing that IFN- acts antiangiogenic in colorectal carcinoma, we investigated the effects of IFN- on the vascular system in IBD.Methods:Colon tissues of patients with IBD and dextran sulfate sodium-induced colitis in mice were subjected to immunohistochemistry, quantitative real-time polymerase chain reactions, and in situ hybridization to quantify cell activation, angiogenesis, and immune responses. Vascular structure and permeability in mice were analyzed by ultramicroscopy and in vivo confocal laser endomicroscopy.Results:We showed a significantly increased blood vessel density in IBD and dextran sulfate sodium colitis. In mice, this was associated with a disorganized blood vessel structure and profound vascular leakage. As compared with genes associated with angiogenesis, genes associated with inflammatory cell activation including IFN- were more strongly upregulated in colitis tissues. IFN- exerted direct effects on endothelial cells in IBD tissues in vivo, as indicated by the expression of IFN--induced guanylate binding protein 1 (GBP-1). Neutralization of IFN- in the acute dextran sulfate sodium colitis model demonstrated that this cytokine exerts endogenous angiostatic activity in IBD and contributes to increased vascular permeability.Conclusions:The dissection of the pleiotropic activities of IFN- in IBD provides new insights to the pathological functions of this cytokine and may be of high relevance for the optimization of combination therapy approaches.